Sanofi India Financial Statements

Sanofi India (SANOFI) reported revenue of ₹18.37B in FY2025 with net income of ₹3.27B. Total assets stood at ₹12.55B. Net worth was ₹7.49B (₹749 Cr) and free cash flow was ₹4.13B.

Sanofi India Income Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Revenue		20.13B	18.37B
Cost of Rev. Cost of Revenue		-9.79B	-8.97B
Gross Profit		10.34B	9.40B
SGA Sales, General & Admin		-5.43B	-4.49B
Op. Income Operating Income		4.54B	4.54B
PBT Profit Before Tax		4.31B	4.45B
Net Income		4.13B	3.27B
Dil. Shares Diluted Shares		23.03M	23.03M
Diluted EPS		179.46	141.85

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Sanofi India's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Sanofi India Balance Sheet

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Curr. assets Total current assets		11.27B	8.01B
Non-curr. assets Total non-current assets		4.85B	4.54B
Total assets		16.12B	12.55B
Curr. liabilities Total current liabilities		7.19B	4.91B
Non-curr. liab. Total non-current liabilities		320.00M	142.00M
Total liabilities		7.51B	5.06B
Total equity		8.61B	7.49B
Total liab. & eq. Total liabilities & equity		16.12B	12.55B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Sanofi India's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Sanofi India Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Net Income		5.62B	4.45B
Operating CF Cash flow Operating Activities		4.62B	4.38B
Capex Investments in PPE		-364.00M	-257.00M
Investing CF Cash flow Investing Activities		-192.00M	-113.00M
Dividend Paid		-3.85B	-4.42B
Financing CF Cash flow Financing Activities		-3.92B	-4.48B
Cash (start) Cash at beginning of period		3.95B	2.84B
Cash (end) Cash at end of period		2.84B	2.63B
FCF Free Cash Flow		4.25B	4.13B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Sanofi India's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Dec-2025